Graypoint LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.32M | Sell |
17,898
-34
| -0.2% | -$6.31K | 0.19% | 96 |
|
|
2025
Q1 | $3.76M | Buy |
17,932
+1,659
| +10% | +$348K | 0.23% | 84 |
|
|
2024
Q4 | $2.89M | Sell |
16,273
-1,247
| -7% | -$222K | 0.18% | 94 |
|
|
2024
Q3 | $3.46M | Buy |
17,520
+1,720
| +11% | +$340K | 0.22% | 82 |
|
|
2024
Q2 | $2.71M | Buy |
15,800
+1,094
| +7% | +$188K | 0.19% | 88 |
|
|
2024
Q1 | $2.68M | Buy |
14,706
+1,680
| +13% | +$306K | 0.19% | 97 |
|
|
2023
Q4 | $2.02M | Sell |
13,026
-2,135
| -14% | -$331K | 0.16% | 110 |
|
|
2023
Q3 | $2.26M | Buy |
15,161
+4,487
| +42% | +$669K | 0.21% | 91 |
|
|
2023
Q2 | $1.44M | Sell |
10,674
-1,667
| -14% | -$225K | 0.14% | 110 |
|
|
2023
Q1 | $1.97M | Buy |
12,341
+2,859
| +30% | +$456K | 0.21% | 89 |
|
|
2022
Q4 | $1.53M | Sell |
9,482
-1,214
| -11% | -$196K | 0.18% | 97 |
|
|
2022
Q3 | $1.44M | Buy |
10,696
+1,541
| +17% | +$207K | 0.18% | 99 |
|
|
2022
Q2 | $1.4M | Sell |
9,155
-839
| -8% | -$128K | 0.18% | 99 |
|
|
2022
Q1 | $1.62M | Buy |
9,994
+3,499
| +54% | +$567K | 0.16% | 104 |
|
|
2021
Q4 | $879K | Buy |
6,495
+1,241
| +24% | +$168K | 0.09% | 147 |
|
|
2021
Q3 | $567K | Sell |
5,254
-704
| -12% | -$76K | 0.07% | 161 |
|
|
2021
Q2 | $671K | Buy |
5,958
+826
| +16% | +$93K | 0.09% | 144 |
|
|
2021
Q1 | $555K | Buy |
5,132
+656
| +15% | +$70.9K | 0.08% | 150 |
|
|
2020
Q4 | $480K | Buy |
4,476
+710
| +19% | +$76.1K | 0.08% | 146 |
|
|
2020
Q3 | $330K | Buy |
3,766
+354
| +10% | +$31K | 0.06% | 155 |
|
|
2020
Q2 | $335K | Buy |
3,412
+326
| +11% | +$32K | 0.08% | 128 |
|
|
2020
Q1 | $235K | Buy |
+3,086
| New | +$235K | 0.07% | 135 |
|